GSK Operating Expenses 2010-2022 | GSK
GSK annual/quarterly operating expenses history and growth rate from 2010 to 2022. Operating expenses can be defined as the sum of all operating expenses for the given industry.
- GSK operating expenses for the quarter ending June 30, 2022 were $7.342B, a 18.14% decline year-over-year.
- GSK operating expenses for the twelve months ending June 30, 2022 were $38.225B, a 7.18% increase year-over-year.
- GSK annual operating expenses for 2021 were $38.383B, a 13.59% increase from 2020.
- GSK annual operating expenses for 2020 were $33.79B, a 1.23% decline from 2019.
- GSK annual operating expenses for 2019 were $34.212B, a 1.16% increase from 2018.
GSK Annual Operating Expenses
(Millions of US $) |
| 2021 |
$38,383 |
| 2020 |
$33,790 |
| 2019 |
$34,212 |
| 2018 |
$33,821 |
| 2017 |
$33,636 |
| 2016 |
$34,277 |
| 2015 |
$20,796 |
| 2014 |
$32,499 |
| 2013 |
$31,083 |
| 2012 |
$30,179 |
| 2011 |
$31,414 |
| 2010 |
$38,053 |
| 2009 |
$31,229 |
GSK Quarterly Operating Expenses
(Millions of US $) |
| 2022-06-30 |
$7,342 |
| 2022-03-31 |
$9,364 |
| 2021-12-31 |
$11,675 |
| 2021-09-30 |
$9,844 |
| 2021-06-30 |
$8,970 |
| 2021-03-31 |
$7,895 |
| 2020-12-31 |
$10,033 |
| 2020-09-30 |
$8,769 |
| 2020-06-30 |
$5,924 |
| 2020-03-31 |
$9,064 |
| 2019-12-31 |
$9,036 |
| 2019-09-30 |
$8,925 |
| 2019-06-30 |
$8,132 |
| 2019-03-31 |
$8,118 |
| 2018-12-31 |
$5,293 |
| 2018-09-30 |
$8,055 |
| 2018-06-30 |
$8,889 |
| 2018-03-31 |
$11,584 |
| 2017-12-31 |
$9,421 |
| 2017-09-30 |
$7,811 |
| 2017-06-30 |
$9,386 |
| 2017-03-31 |
$7,018 |
| 2016-12-31 |
$8,689 |
| 2016-09-30 |
$8,026 |
| 2016-06-30 |
$9,589 |
| 2016-03-31 |
$7,889 |
| 2015-12-31 |
$-3,744 |
| 2015-09-30 |
$8,064 |
| 2015-06-30 |
$8,600 |
| 2015-03-31 |
$7,876 |
| 2014-12-31 |
$9,377 |
| 2014-09-30 |
$7,762 |
| 2014-06-30 |
$7,718 |
| 2014-03-31 |
$7,642 |
| 2013-12-31 |
$7,566 |
| 2013-09-30 |
$7,804 |
| 2013-06-30 |
$8,007 |
| 2013-03-31 |
$7,706 |
| 2012-12-31 |
$7,216 |
| 2012-09-30 |
$7,659 |
| 2012-06-30 |
$7,589 |
| 2012-03-31 |
$7,715 |
| 2011-12-31 |
$7,267 |
| 2011-09-30 |
$8,189 |
| 2011-06-30 |
$8,167 |
| 2011-03-31 |
$7,792 |
| 2010-12-31 |
$11,906 |
| 2010-09-30 |
$7,524 |
| 2010-06-30 |
$10,404 |
| 2010-03-31 |
$8,218 |
| 2009-12-31 |
$9,138 |
| 2009-09-30 |
$7,694 |
| 2009-06-30 |
$7,047 |
| 2009-03-31 |
$7,350 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$81.408B |
$46.910B |
|
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
|
